`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`STEADYMED LTD.
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION
`Patent Owner
`
`
`U.S. Patent No. 8,497,393
`Issue Date: Jul. 30, 2013
`Title: PROCESS TO PREPARE TREPROSTINIL, THE ACTIVE
`INGREDIENT IN REMODULIN®
`_______________
`
`Case IPR2016-00006
`_______________
`
`
`PATENT OWNER’S ITEMIZED LIST RESPONSIVE TO BOARD’S
`ORDER (PAPER NO. 56)
`
`
`
`
`
`
`4850-9319-7872.1
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Pursuant to the Board’s Order in Paper No. 56, Patent Owner United
`
`Therapeutics Corporation (“Patent Owner”) hereby submits an itemized list of
`
`portions of Petitioner’s Reply and the Roger’s Declaration which (1) contain new
`
`argument that exceeds the scope of Patent Owner’s Response, (2) improperly
`
`incorporates material or (3) mischaracterizes the testimony of Patent Owner’s
`
`expert, Dr. Williams.
`
`(1) Portions That Contain New Argument
`
`(a) Rogers Declaration (Ex. 1022), p. 21, line 4 from the end of the page
`
`through p. 24, last line; and
`
`(b) Rogers Declaration (Ex. 1022), p. 29, first line through p. 30, line 4.
`
`(2) Portions That Improperly Incorporate Material
`
`(a) Petitioner’s Reply, p. 13, line 8;
`
`(b) Rogers Declaration (Ex. 1022), p. 9, line 8 through p. 24, last line;
`
`(c) Rogers Declaration (Ex. 1022), p. 26, line 7 from the end of the page
`
`through p. 30, line 4;
`
`(d) Rogers Declaration (Ex. 1022), p. 30, line 11 (beginning of Section VIII.A.)
`
`through p. 34, line 6 from the end of the page;
`
`(e) Rogers Declaration (Ex. 1022), p. 35, line 1 through p. 36, last line; and
`
`(f) Rogers Declaration (Ex. 1022), p. 37, line 4 through p. 38, last line.
`
`4850-9319-7872.1
`
`2
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`(3) Portions That Mischaracterize the Testimony of Patent Owner’s Expert
`
`As offered by the Board during the conference call held on Oct. 6, 2016, Patent
`
`Owner elects to clarify Petitioner’s mischaracterization of Dr. Williams’ testimony
`
`in its demonstratives at the final hearing by citing to the deposition transcript.
`
`
`
`Date: October 12, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`4850-9319-7872.1
`
`3
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Attorney Docket No. 080618-1601
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Itemized List Responsive To Board’s Order (Paper No. 56) was served on
`
`counsel of record on October 12, 2016, by filing this document through the PTAB
`
`E2E System as well as delivering a copy via email to the counsel of record for the
`
`Petitioner at the following address: Steadymed-IPR@dlapiper.com.
`
`
`
`
`
`
`
`
`
`
`
`Date: October 12, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Foley & Lardner LLP
`
`
`
`
`
`
`
`4850-9319-7872.1
`
`